Free Trial

Theriva Biologics (TOVX) Insider Trading & Ownership

Theriva Biologics logo
$1.98
-0.01 (-0.50%)
(As of 12:50 PM ET)

Theriva Biologics (NYSEAMERICAN:TOVX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.05%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$106,380.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get TOVX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theriva Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TOVX Insider Buying and Selling by Quarter

Theriva Biologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2023Steven A ShallcrossCEOBuy1,040$15.75$16,380.00  
2/10/2023Steven A ShallcrossCEOBuy1,000$26.00$26,000.00  
2/2/2023Steven A ShallcrossCEOBuy1,000$23.50$23,500.00  
1/25/2023Steven A ShallcrossCEOBuy1,000$21.75$21,750.00  
1/20/2023Steven A ShallcrossCEOBuy1,000$18.75$18,750.00  
(Data available from 1/1/2013 forward)

TOVX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Theriva Biologics includes Steven A Shallcross. Learn more on insiders at TOVX.

3.05% of Theriva Biologics stock is owned by insiders. Learn more on TOVX's insider holdings.

The following insider purchased TOVX shares in the last 24 months: Steven A Shallcross ($106,380.00).

Insiders have purchased a total of 5,040 TOVX shares in the last 24 months for a total of $106,380.00 bought.

Theriva Biologics Key Executives

  • Mr. Steven A. Shallcross CPA (Age 63)
    CEO, CFO, Treasurer, Corporate Secretary & Director
    Compensation: $993.46k
  • Dr. Vince Wacher Ph.D.
    Head of Product & Corporate Development
  • Dr. Michael Kaleko M.D.
    Ph.D., Senior Vice President of Research & Development
  • Dr. Ramon Alemany Ph.D.
    Senior VP of Discovery & Chairman of Scientific Advisory Board


This page (NYSEAMERICAN:TOVX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners